DMBT1 is upregulated in lung epithelial cells after hypoxia and changes surfactant ultrastructure.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
11 2020
Historique:
received: 18 05 2020
accepted: 05 08 2020
pubmed: 10 8 2020
medline: 25 2 2021
entrez: 10 8 2020
Statut: ppublish

Résumé

Hypoxia and asphyxia are known to induce surfactant inactivation in newborns. Deleted in Malignant Brain Tumors 1 (DMBT1) is an innate immunity protein with functions in epithelial differentiation and angiogenesis. It was detected in hyaline membranes of infants with respiratory distress syndrome. Human recombinant DMBT1 is able to increase the surface tension of exogenous surfactant preparations in a dose-dependent manner. Immunohistochemistry was performed on lung sections of infants who died due to pre-, peri- or postnatal hypoxia. The lung epithelial cell line A549 was stably transfected with a DMBT1 (DMBT1+ cells) expression plasmid or with an empty plasmid (DMBT1- cells). The cells were cultured in normoxic or hypoxic conditions, and then DMBT1 as well as HIF-1α RNA expression were analyzed by using real-time-polymerase chain reaction. Human recombinant DMBT1 was added to the modified porcine natural surfactant Curosurf to examine the effect of DMBT1 on surfactant ultrastructure with electron microscopy. DMBT1 expression was upregulated in human lung tissue after fetal/peri-/postnatal hypoxia. In addition, in vitro experiments showed increased DMBT1 RNA expression in A549 cells after hypoxia. HIF-1α was upregulated in both DMBT1+ and DMBT1- cells in response to hypoxia. The addition of human recombinant DMBT1 to Curosurf caused an impaired surfactant ultrastructure. DMBT1 is upregulated in response to hypoxia and there seems to be a link between hypoxia and surfactant inactivation.

Sections du résumé

BACKGROUND
Hypoxia and asphyxia are known to induce surfactant inactivation in newborns. Deleted in Malignant Brain Tumors 1 (DMBT1) is an innate immunity protein with functions in epithelial differentiation and angiogenesis. It was detected in hyaline membranes of infants with respiratory distress syndrome. Human recombinant DMBT1 is able to increase the surface tension of exogenous surfactant preparations in a dose-dependent manner.
METHODS
Immunohistochemistry was performed on lung sections of infants who died due to pre-, peri- or postnatal hypoxia. The lung epithelial cell line A549 was stably transfected with a DMBT1 (DMBT1+ cells) expression plasmid or with an empty plasmid (DMBT1- cells). The cells were cultured in normoxic or hypoxic conditions, and then DMBT1 as well as HIF-1α RNA expression were analyzed by using real-time-polymerase chain reaction. Human recombinant DMBT1 was added to the modified porcine natural surfactant Curosurf to examine the effect of DMBT1 on surfactant ultrastructure with electron microscopy.
RESULTS
DMBT1 expression was upregulated in human lung tissue after fetal/peri-/postnatal hypoxia. In addition, in vitro experiments showed increased DMBT1 RNA expression in A549 cells after hypoxia. HIF-1α was upregulated in both DMBT1+ and DMBT1- cells in response to hypoxia. The addition of human recombinant DMBT1 to Curosurf caused an impaired surfactant ultrastructure.
CONCLUSIONS
DMBT1 is upregulated in response to hypoxia and there seems to be a link between hypoxia and surfactant inactivation.

Identifiants

pubmed: 32770804
doi: 10.1002/ppul.25018
doi:

Substances chimiques

Biological Products 0
Calcium-Binding Proteins 0
DMBT1 protein, human 0
DNA-Binding Proteins 0
Phospholipids 0
Pulmonary Surfactants 0
Tumor Suppressor Proteins 0
poractant alfa KE3U2023NP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2964-2969

Informations de copyright

© 2020 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.

Références

Fehrenbach A, Ochs M, Warnecke T, et al. Beneficial effect of lung preservation is related to ultrastructural integrity of tubular myelin after experimental ischemia and reperfusion. Am J Respir Crit Care Med. 2000;161:2058-2065.
Ochs M, Nenadic I, Fehrenbach A, et al. Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am J Respir Crit Care Med. 1999;160:718-724.
Sulkowska M. Morphological studies of the lungs in chronic hypobaric hypoxia. Pol J Pathol. 1997;48:225-234.
Wirbelauer J, Speer CP. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome. J Perinatol. 2009;29(suppl 2):S18-S22.
Müller H, End C, Renner M, et al. Deleted in malignant brain tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant. Respir Res. 2007;8:69.
Müller H, End C, Weiss C, et al. Respiratory deleted in malignant brain tumours 1 (DMBT1) levels increase during lung maturation and infection. Clin Exp Immun. 2008;151:123-129.
Müller H, Weiss C, Renner M, Felderhoff-Müser U, Mollenhauer J. DMBT1 promotes basal and meconium-induced nitric oxide production in human lung epithelial cells in vitro. Histochem Cell Biol. 2017;147:389-397.
Müller H, Nagel C, Weiss C, Mollenhauer J, Poeschl J. Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells. BMC Pulm Med. 2015;15:32.
Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL. Characterization of the A549 cell lines as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res. 1998;243:359-366.
End C, Lyer S, Renner M, et al. Generation of a vector system facilitating cloning of DMBT1 variants and recombinant expression of functional full-length DMBT1. Protein Expr Purif. 2005;41:275-286.
Schmiedl A, Krug N, Hohlfeld JM. Influence of plasma and inflammatory proteins on the ultrastructure of exogenous surfactant. J Electron Microscopy. 2004;53:407-416.
Hartshorn KL, White MR, Mogues T, Ligtenberg T, Crouch E, Holmskov U. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol. 2003;285:L1066-L1076.
Holmskov U, Lawson P, Teisner B, et al. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem. 1997;272:13743-13749.
Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol. 1986;60:532-538.
Müller H, Hu J, Popp R, et al. Deleted in malignant brain tumors 1 is present in the vascular extracellular matrix and promotes angiogenesis. Arterioscler Thromb Vasc Biol. 2012;32:442-448.
Xie Y, Qi Y, Zhang Y, Chen J, Wu T, Gu Y. Regulation of angiogenic factors by the PI3K/Akt pathway in A549 lung cancer cells under hypoxic conditions. Oncol Lett. 2017;13:2909-2914.
Wiener CM, Booth G, Semenza GL. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun. 1996;225:485-488.
Li X, Liu X, Xu Y, et al. KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1α. Int J Oncol. 2014;45:1507-1514.
Uchida T, Rossignol F, Matthay MA, et al. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1α and HIF-2α expression in lung epithelial cells. J Biol Chem. 2004;279:14871-14878.
Ochs M, Schüttler M, Stichtenoth G, Herting E. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran. Respir Res. 2006;7:86.
Ochs M. The closer we look the more we see? Quantitative microscopic analysis of the pulmonary surfactant system. Cell Physiol Biochem. 2010;25:27-40.
Poulain FR, Allen L, Williams MC, Hamilton RL, Hawgood S. Effects of surfactant apolipoproteins on liposome structure: implications for tubular myelin formation. Am J Physiol. 1992;262(6 Pt 1):L730-L739.

Auteurs

Hanna Müller (H)

Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany.

Andreas Schmiedl (A)

Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany.

Christel Weiss (C)

Department for Medical Statistics and Biomathematics, University Hospital Mannheim, Mannheim, Germany.

Maria Ai (M)

Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany.

Susan Jung (S)

Department of Pediatrics, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany.

Marcus Renner (M)

Institute of Pathology, University of Heidelberg, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH